Name: Nuvectis Pharma, Inc. (NVCT) Balance Sheet
Creator: FinSpry

Nuvectis Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Nuvectis Pharma, Inc. (NVCT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	31.63	18.53	19.13	19.99	5.74	0.00
Cash & Short-Term Investments	31.63	18.53	19.13	19.99	5.74	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.08	0.07	0.06	0.41	0.09	0.00
Total Current Assets	31.71	18.61	19.19	20.41	5.83	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.00	0.00	0.00	0.00	0.82	0.00
Total Assets	31.71	18.61	19.19	20.41	6.66	0.00
Current Liabilities
Accounts Payable	6.27	2.50	2.77	2.91	1.06	0.01
Accrued Liabilities	0.00	6.40	0.42	2.83	0.40	0.00
Other Current Liabilities	7.02	6.40	3.80	0.45	0.82	0.00
Total Current Liabilities	13.30	8.89	6.98	6.19	2.42	0.01
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.45	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.45	15.25	0.00
Total Liabilities	13.30	8.89	6.98	6.19	17.67	0.01
Stockholders' Equity
Retained Earnings	-99.69	-73.25	-54.25	-31.99	-12.90	-0.01
Additional Paid-in Capital	118.10	82.96	66.45	46.20	1.89	0.00
Shares Outstanding	0.00	19.50	17.42	14.64	12.72	0.00
Total Stockholders' Equity	18.41	9.71	12.20	14.22	-11.01	-0.01
Total Liabilities & Equity	31.71	18.61	19.19	20.41	6.66	0.00